Kathmere Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.1M Buy
4,463
+824
+23% +$835K 0.25% 75
2025
Q4
$3.91M Sell
3,639
-33
-0.9% -$31.6K 0.26% 76
2025
Q3
$2.8M Sell
3,672
-307
-8% -$228K 0.2% 92
2025
Q2
$3.1M Sell
3,979
-270
-6% -$210K 0.24% 75
2025
Q1
$3.51M Buy
4,249
+101
+2% +$84K 0.3% 59
2024
Q4
$3.2M Buy
4,148
+229
+6% +$190K 0.29% 62
2024
Q3
$3.47M Sell
3,919
-67
-2% -$60.2K 0.33% 53
2024
Q2
$3.61M Sell
3,986
-661
-14% -$529K 0.38% 47
2024
Q1
$3.62M Sell
4,647
-224
-5% -$159K 0.41% 44
2023
Q4
$2.84M Buy
4,871
+2
+0% +$1.17K 0.37% 47
2023
Q3
$2.62M Buy
4,869
+746
+18% +$384K 0.39% 49
2023
Q2
$1.93M Buy
4,123
+45
+1% +$18.9K 0.3% 53
2023
Q1
$1.4M Sell
4,078
-508
-11% -$171K 0.23% 56
2022
Q4
$1.68M Buy
4,586
+1,073
+31% +$380K 0.3% 53
2022
Q3
$1.14M Buy
3,513
+822
+31% +$260K 0.23% 58
2022
Q2
$873K Buy
2,691
+1,299
+93% +$390K 0.16% 58
2022
Q1
$399K Buy
+1,392
New +$358K 0.07% 98

Other funds holding LLY

Kathmere Capital Management's LLY Position: Q1 2026 in Review

Kathmere Capital Management increased its Eli Lilly (LLY) stake by 23% in Q1 2026, buying an estimated $835K and bringing the position to 4,463 shares worth $4.1M. The position accounts for 0.25% of the portfolio, ranked #75.

Kathmere Capital Management first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Kathmere Capital Management held 4,463 shares of Eli Lilly worth $4.1M as of Q1 2026.
  • Kathmere Capital Management bought 824 Eli Lilly shares in Q1 2026, an estimated $835K.
  • Eli Lilly made up 0.25% of Kathmere Capital Management's portfolio in Q1 2026, its #75 holding.
  • Kathmere Capital Management first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kathmere Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.